Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001140361-16-057611

Director sold 14,820 shares at $35.34 ($523,739)

  • Director acquired 14,820 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

SULLIVAN LOUIS W · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-03-10 Exercise or conversion : show line 1 in the form +14,820 $10.28 $152,350 43,320 D
2016-03-10 Sale : show line 2 in the form −14,820 $35.34 $523,739 28,500 D
Open-market sales · 14,820 sh · avg $35.34 · $523,739

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-03-10 Exercise or conversion : show line 3 in the form Stock Option −14,820 $10.28 2016-06-29 14,820 14,879 D
Loading xslF345X03/doc1.xml…